Five notes:
1. For the fourth quarter, the company expects sales to be approximately $195.5 million, an 11 percent increase year over year.
2. Globus Medical expects full-year sales to be approximately $712.5 million, a 12 percent hike year over year.
3. The company’s emerging technologies segment is predicted to have generated $14.8 million in the fourth quarter, a 35 percent increase year over year.
4. Within its U.S. spinal implant business, Globus Medical estimates a 9 percent increase year over year.
5. In 2019, Globus Medical predicts year-end sales will be approximately $770 million.
More articles on devices and implants:
Barclays analyst criticizes Medtronic — Here’s what CEO Omar Ishrak had to say
Medtronic issues Class 1 recall of cranial software: 5 things to know
Integra LifeSciences develops short stem, stemless shoulder system: 3 insights
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
